BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6689423)

  • 1. Central nervous system involvement in American Burkitt's lymphoma.
    Sariban E; Edwards B; Janus C; Magrath I
    J Clin Oncol; 1983 Nov; 1(11):677-81. PubMed ID: 6689423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
    Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
    J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
    Spreafico F; Massimino M; Luksch R; Casanova M; Cefalo GS; Collini P; Ferrari A; Polastri D; Terenziani M; Gasparini M; Fossati-Bellani F
    J Clin Oncol; 2002 Jun; 20(12):2783-8. PubMed ID: 12065554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults.
    Magrath IT; Janus C; Edwards BK; Spiegel R; Jaffe ES; Berard CW; Miliauskas J; Morris K; Barnwell R
    Blood; 1984 May; 63(5):1102-11. PubMed ID: 6546890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
    Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM
    Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of CNS leukemia with intraventricular chemotherapy and low-dose neuraxis radiotherapy.
    Steinherz P; Jereb B; Galicich J
    J Clin Oncol; 1985 Sep; 3(9):1217-26. PubMed ID: 3861774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma.
    Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA
    Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive chemotherapy and autologous bone marrow transplantation in Burkitt's lymphoma: the first two patients successfully treated in Thailand.
    Suvatte V; Issaragrisil S; Chandanayingyong D; Mahasandana C; Tanphaichitr VS; Jirapinyo P
    J Med Assoc Thai; 1990 Oct; 73(10):572-80. PubMed ID: 2280205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
    Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types).
    Bernstein JI; Coleman CN; Strickler JG; Dorfman RF; Rosenberg SA
    J Clin Oncol; 1986 Jun; 4(6):847-58. PubMed ID: 3711961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophthalmoparesis due to Burkitt's lymphoma following cardiac transplantation.
    Liu GT; Kay MD; Byrne GE; Glaser JS; Schatz N
    Neurology; 1993 Oct; 43(10):2147-9. PubMed ID: 8413988
    [No Abstract]   [Full Text] [Related]  

  • 13. Excessive spinal cord toxicity from intensive central nervous system-directed therapies.
    Watterson J; Toogood I; Nieder M; Morse M; Frierdich S; Lee Y; Moertel CL; Priest JR
    Cancer; 1994 Dec; 74(11):3034-41. PubMed ID: 7954266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive therapy and autologous bone marrow transplantation in very bad prognosis Burkitt's lymphoma.
    Philip T; Biron P; Philip I; Favrot M; Souillet G; Philippe N; Hervé P; Plouvier E; Bernard JL; Raybaud C
    IARC Sci Publ; 1985; (60):419-34. PubMed ID: 3905593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal chemoprophylaxis in the prevention of central nervous system relapse in Burkitt's lymphoma.
    Nkrumah FK; Neequaye JE; Biggar R
    Cancer; 1985 Jul; 56(2):239-42. PubMed ID: 3839158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C
    J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.
    Singhal S; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Mehta J
    Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of 40 children with Burkitt's and Burkitt-like lymphoma].
    Zhang YH; Duan YL; Yang J; Jin L; Zhou CJ; Gao ZF
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):209-14. PubMed ID: 19099711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system (CNS) leukemia: the role of high dose cytarabine (HDAra-C).
    Morra E; Lazzarino M; Alessandrino EP; Inverardi D; Regazzi Bonora M; Pagnucco G; Orlandi E; Bernasconi P; Canevari A; Rondanelli R
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():101-3. PubMed ID: 2713552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose cyclophosphamide and intermediate-dose methotrexate for the treatment of far-advanced Burkitt's lymphoma.
    Brecher ML; Gardner RV; Ettinger LJ; Tebbi CK; Green DM; Freeman AI
    Am J Pediatr Hematol Oncol; 1985; 7(2):117-24. PubMed ID: 3842557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.